Stockreport

Foghorn Therapeutics Announces Upcoming Investor Conference Participation [MarketWatch]

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, May 31, 2022 (GLOBE NEWSWIRE via COMTEX) -- CAMBRIDGE, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Foghorn (R) Therapeutics Inc. (Nasdaq: FHTX), a company pionee [Read more]